Biotech: Page 62

  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    What's on Your Mind -- Opinions

    What’s on Your Mind Opinions Security: Big Brother Really Could Be Watching In September, PharmaVOICE’s feature article, Biometrics — Beyond Passwords, examined the potential use of biological markers, such as fingerprints and iris scans, in the pharmaceutical industry to ensure security. The Com...

    By PharmaVoice Team • Jan. 2, 2008
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Table of Contents

    PharmaVOICE — October 2004 Table of Contents Download PDF

    By PharmaVoice Team • Jan. 2, 2008
  • cancer R&D Explore the Trendline➔
    Image attribution tooltip
    Getty Images
    Image attribution tooltip
    Trendline

    Oncology R&D

    Cancer research remains a prime focus for the industry and often leads to pharma’s most impactful breakthroughs.   

    By PharmaVoice staff
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    What's New

    What’s New New healthcare-related products, services, and companies Elsevier/International Medical News Group Launches Clinical Neurology News Elsevier/International Medical News Group (IMNG) is set to launch Clinical Neurology News in January 2005. Clinical Neurology News, a monthly publication,...

    By PharmaVoice Team • Jan. 2, 2008
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Talent Pool

    Talent Pool Executive Appointments and Promotions Pharma POOL Michael D. Kishbauch Achillion Appoints CEO Achillion Pharmaceuticals has named Michael D. Kishbauch CEO. Mr. Kishbauch replaces Marios Fotiadis, who was acting as interim CEO. Before joining Achillion, New Haven, Conn., Mr. Kishbauch ...

    By PharmaVoice Team • Jan. 2, 2008